DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 208 filers reported holding DEPOMED INC in Q4 2016. The put-call ratio across all filers is 0.40 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $164,000 | -28.4% | 24,598 | -29.2% | 0.01% | -38.5% |
| Q1 2018 | $229,000 | -46.7% | 34,734 | -35.0% | 0.01% | -43.5% |
| Q4 2017 | $430,000 | +75.5% | 53,448 | +26.5% | 0.02% | +64.3% |
| Q3 2017 | $245,000 | -69.3% | 42,250 | -33.6% | 0.01% | -75.4% |
| Q1 2017 | $799,000 | +137.1% | 63,676 | +240.8% | 0.06% | +111.1% |
| Q4 2016 | $337,000 | -42.6% | 18,683 | -55.6% | 0.03% | -20.6% |
| Q1 2016 | $587,000 | -59.8% | 42,114 | -47.7% | 0.03% | -60.5% |
| Q4 2015 | $1,461,000 | -35.1% | 80,574 | -32.5% | 0.09% | -24.6% |
| Q3 2015 | $2,251,000 | +215.7% | 119,415 | +259.4% | 0.11% | +225.7% |
| Q2 2015 | $713,000 | +45.2% | 33,228 | +51.6% | 0.04% | +45.8% |
| Q1 2015 | $491,000 | +234.0% | 21,925 | +140.1% | 0.02% | +200.0% |
| Q4 2014 | $147,000 | +241.9% | 9,131 | +226.1% | 0.01% | +166.7% |
| Q3 2014 | $43,000 | -89.8% | 2,800 | -90.7% | 0.00% | -88.0% |
| Q2 2014 | $421,000 | – | 30,252 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DELTEC ASSET MANAGEMENT LLC | 2,252,402 | $31,376,000 | 7.88% |
| Healthcare Value Capital, LLC | 350,000 | $4,876,000 | 7.16% |
| Senvest Management, LLC | 4,977,256 | $69,333,000 | 5.82% |
| Consonance Capital Management LP | 2,756,360 | $38,396,000 | 5.81% |
| Opaleye Management Inc. | 325,000 | $4,527,000 | 2.82% |
| Krensavage Asset Management, LLC | 447,000 | $6,227,000 | 2.23% |
| Healthcare Value Capital, LLC | 100,000 | $1,393,000 | 2.05% |
| Starboard Value LP | 2,950,000 | $41,094,000 | 1.44% |
| HealthInvest Partners AB | 200,000 | $2,786,000 | 1.30% |
| OAK RIDGE INVESTMENTS LLC | 7,206,286 | $100,384,000 | 1.29% |